Last reviewed · How we verify
NCT07214012
Planning Together: A Couple-based, Multi-level Prenatal Contraceptive Education Program for Economically Marginalized Families
NA trial testing Joint contraceptive and couple communication education in Short Interpregnancy Intervals in 60 participants. Not yet recruiting.
14 October 2026
Quick facts
| Lead sponsor | University of Tennessee Graduate School of Medicine |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 60 |
| Start date | 15 October 2025 |
| Primary completion | 14 October 2026 |
| Estimated completion | 14 October 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Joint contraceptive and couple communication education
- Couple communication consultation with Interventionist to increase partner engagement and improve communication
- Check-ins to support continued partner support & communication
- Check-ins to support continued partner support & communication
Conditions studied
- Short Interpregnancy Intervals — all drugs for Short Interpregnancy Intervals →
- Maternal Health Disparities — all drugs for Maternal Health Disparities →
Sponsor
University of Tennessee Graduate School of Medicine
Who can join
18 and older, any sex, with Short Interpregnancy Intervals or Maternal Health Disparities. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this pilot trial is to examine the feasibility and acceptability of the Planning Together protocol The hypothesis of this study are 1. The study will achieve feasibility, demonstrated by ≥80% study accrual (30 couples in 8 months), ≥75% protocol adherence, and ≥75% (e.g., education workbook completion) 2. The intervention will be acceptable, with \>80% of participants reporting satisfaction with Planning Together. 3. Patterns of primary outcomes (contraceptive knowledge, communication quality, community referral utilization) and secondary outcomes (agreed contraceptive plan, consistent contraceptive usage and satisfaction, psychological distress, and Short Interpregnancy Intervals \[SII\]) will suggest benefits of the intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07214012
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Tennessee Graduate School of Medicine trials
Trials by the same sponsor.
- NCT07223437 — REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennesse · NA · not yet recruiting
- NCT07205068 — Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and P · NA · recruiting
- NCT06953635 — Quadratus Lumborum Versus Placebo in Open Ventral Hernia Repair · NA · not yet recruiting
- NCT07153614 — Efficacy of Perioperative Opioid Sparing Techniques on Time to Initiation of Chemotherapy · NA · recruiting
- NCT06802861 — Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclam · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07214012 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Tennessee Graduate School of Medicine
- Last refreshed: 9 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07214012.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing